Bromhexine Hydrochloride

Basic Information

Item Value
DrugBank ID DB09019
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 vulvitis KG + DL
2 vaginitis (disease) KG + DL
3 catatrichy KG + DL
4 vulvovaginitis KG + DL
5 irritable bowel syndrome KG + DL
6 keratosis follicularis spinulosa decalvans, autosomal dominant KG + DL
7 ulceration of vulva KG + DL
8 vulvar neoplasm KG + DL
9 bacterial vaginosis KG + DL
10 vaginal discharge KG + DL
11 leukoplakia of vagina KG + DL
12 folliculitis KG + DL
13 postmenopausal atrophic vaginitis KG + DL
14 pharyngitis KG + DL
15 benign prostatic hyperplasia (disease) KG + DL
16 nasal cavity disease KG + DL
17 trichomonal vulvovaginitis KG + DL
18 acute laryngopharyngitis KG + DL
19 seborrheic dermatitis KG + DL
20 vulvovaginal candidiasis KG + DL
21 genital herpes KG + DL
22 toxocariasis KG + DL
23 peripheral arterial disease KG + DL
24 herpetic vulvovaginitis KG + DL
25 strongyloidiasis KG + DL
26 breast fibrocystic disease KG + DL
27 toxascariasis KG + DL
28 anisakiasis KG + DL
29 ischemic disease KG + DL
30 thrombotic disease KG + DL
31 apocrine adenosis of breast KG + DL
32 blunt duct adenosis of breast KG + DL
33 rhinitis KG + DL
34 herpes zoster KG + DL
35 cervical artery dissection KG + DL
36 piedra KG + DL
37 cutaneous larva migrans KG + DL
38 ciliary body disease KG + DL
39 disease of orbital region KG + DL
40 sequela of COVID-19 KG + DL
41 peripheral vascular disease KG + DL
42 post-infectious neuralgia KG + DL
43 herpes simplex virus keratitis KG + DL
44 iritis (disease) KG + DL
45 seborrheic keratosis KG + DL
46 hepatitis C induced liver cirrhosis KG + DL
47 disease of orbital part of eye adnexa KG + DL
48 anogenital human papillomavirus infection KG + DL
49 spinal cord dermoid cyst KG + DL
50 angiodysplasia KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.